Pretreatment long interspersed element (LINE)-1 methylation levels, not early hypomethylation under treatment, predict hematological response to azacitidine in elderly patients with acute myeloid leukemia

BACKGROUND: Epigenetic modulations, including changes in DNA cytosine methylation, are implicated in the pathogenesis and progression of acute myeloid leukemia (AML). Azacitidine is a hypomethylating agent that is incorporated into RNA as well as DNA. Thus, there is a rationale to its use in patient...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Cross, Michael, Bach, Enrica, Tran, Thao, Krahl, Rainer, Jaekel, Nadja, Niederwieser, Dietger, Junghanss, Christian, Maschmeyer, Georg, Al-Ali, Haifa Kathrin
Format: Artigo
Idioma:Inglês
Publicat: Dove Medical Press 2013
Matèries:
Original Research
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC3699298/
https://ncbi.nlm.nih.gov/pubmed/23836986
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/OTT.S45459
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars